Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: Implications for controlling dietary carbohydrates: A review

被引：192
作者：
Freedland E.S. [1 ]
机构：
[1] Boston University, School of Medicine, Marblehead, MA 01945, 5 Bessom Street
来源：
Nutrition & Metabolism | / 1卷 / 1期
关键词：
Insulin Resistance; Metabolic Syndrome; Visceral Adipose Tissue; Glycemic Index; Glycemic Load;
D O I：
10.1186/1743-7075-1-12
中图分类号：
学科分类号：
摘要：
There are likely many scenarios and pathways that can lead to metabolic syndrome. This paper reviews mechanisms by which the accumulation of visceral adipose tissue (VAT) may contribute to the metabolic syndrome, and explores the paradigm of a critical VAT threshold (CVATT). Exceeding the CVATT may result in a number of metabolic disturbances such as insulin resistance to glucose uptake by cells. Metabolic profiles of patients with visceral obesity may substantially improve after only modest weight loss. This could reflect a significant reduction in the amount of VAT relative to peripheral or subcutaneous fat depots, thereby maintaining VAT below the CVATT. The CVATT may be unique for each individual. This may help explain the phenomena of apparently lean individuals with metabolic syndrome, the so-called metabolically normal weight (MONW), as well as the obese with normal metabolic profiles, i.e., metabolically normal obese (MNO), and those who are "fit and fat." The concept of CVATT may have implications for prevention and treatment of metabolic syndrome, which may include controlling dietary carbohydrates. The identification of the CVATT is admittedly difficult and its anatomical boundaries are not well-defined. Thus, the CVATT will continue to be a work in progress. © 2004 Freedland; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 156 条
  • [1] Bjorntorp P., Metabolic implications of body fat distribution, Diabetes Care, 14, pp. 1132-1143, (1991)
  • [2] Lamarche B., Abdominal obesity and its metabolic complications: Implications for the risk of ischaemic heart disease, Coron Artery Dis, 9, pp. 473-481, (1998)
  • [3] Lafontan M., Berlan M., Do regional differences in adipocyte biology provide new pathophysiological insights?, Trends Pharmacol Sci, 24, pp. 276-283, (2003)
  • [4] Montague C.T., O'Rahilly S., The perils of portliness: Causes and consequences of visceral adiposity, Diabetes, 49, pp. 883-888, (2000)
  • [5] Wajchenberg B.L., Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome, Endocr Rev, 21, pp. 697-738, (2000)
  • [6] Ross R., Goodpaster B., Kelley D., Boada F., Magnetic resonance imaging in human body composition research. From quantitative to qualitative tissue measurement, Ann N Y Acad Sci, 904, pp. 12-17, (2000)
  • [7] Ravussin E., Smith S.R., Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus, Ann N Y Acad Sci, 967, pp. 363-378, (2002)
  • [8] Kim S.K., Kim H.J., Hur K.Y., Choi S.H., Ahn C.W., Lim S.K., Kim K.R., Lee H.C., Huh K.B., Cha B.S., Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases, Am J Clin Nutr, 79, pp. 593-599, (2004)
  • [9] Blair D., Habicht J.P., Sims E.A., Sylwester D., Abraham S., Evidence for an increased risk for hypertension with centrally located body fat and the effect of race and sex on this risk, Am J Epidemiol, 119, pp. 526-540, (1984)
  • [10] Bergstrom R.W., Newell-Morris L.L., Leonetti D.L., Shuman W.P., Wahl P.W., Fujimoto W.Y., Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men, Diabetes, 39, pp. 104-111, (1990)
12345678910